WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?

Insider buying vs selling

Have Mirum Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Patrick J. HeronDirector2024-09-06230$41.58
$9.56kBuy
Christopher PeetzCHIEF EXECUTIVE OFFICER2024-07-2334,013$2.94
$99.86kBuy
Jolanda HoweSVP GLOBAL CONTROLLER2024-07-02375$34.00
$12.75kSell
Pamela VigCHIEF SCIENTIFIC OFFICER2024-06-2430,559$2.94
$89.72kBuy
Pamela VigCHIEF SCIENTIFIC OFFICER2024-06-2430,559$34.00
$1.04MSell
Saira RamasastryDirector2024-06-055,000$14.12
$70.60kBuy
Saira RamasastryDirector2024-06-055,000$25.68
$128.40kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2024-05-10817$21.05
$17.19kBuy
Eric BjerkholtCHIEF FINANCIAL OFFICER2024-05-10470$21.05
$9.89kBuy
Pamela VigCHIEF SCIENTIFIC OFFICER2024-05-1094$21.05
$1.98kBuy

1 of 4

MIRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRM insiders and whales buy or sell their stock.

MIRM Shareholders

What type of owners hold Mirum Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP13.62%6,495,392$266.51MInstitution
Janus Henderson Group PLC10.46%4,988,747$204.69MInstitution
Bvf Inc9.16%4,370,024$179.30MInstitution
Peter W. Sonsini8.77%4,186,243$171.76MInsider
Peter J. Barris8.77%4,186,243$171.76MInsider
Joshua Makower8.77%4,186,243$171.76MInsider
David M. Mott8.77%4,186,243$171.76MInsider
Patrick J. Heron7.82%3,729,105$153.01MInsider
Eventide Asset Management LLC7.58%3,614,820$148.32MInstitution
Frazier Life Sciences Ix LP7.48%3,566,912$146.35MInsider

1 of 3

MIRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRM50.42%49.58%Net BuyingNet Buying
GPCR34.55%12.02%Net BuyingNet Buying
ZLAB4.07%1.95%Net SellingNet Selling
NVAX52.12%17.16%Net SellingNet Selling
BEAM80.49%19.51%Net SellingNet Selling

Mirum Pharmaceuticals Stock Ownership FAQ

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals (NASDAQ: MIRM) is owned by 111.32% institutional shareholders, 109.47% Mirum Pharmaceuticals insiders, and 0.00% retail investors. Peter W. Sonsini is the largest individual Mirum Pharmaceuticals shareholder, owning 4.19M shares representing 8.77% of the company. Peter W. Sonsini's Mirum Pharmaceuticals shares are currently valued at $174.86M.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.